Outcomes of Implants Following Breast Conservation Therapy with History of Augmentation Mammaplasty

Overview

About this study

The purpose of this study is to identify the incidence of patient perceived implant contracture and/or patient perceived unsatisfactory cosmetic outcome of breast implants following breast conserving surgery and radiation. Also, to determine risk factors that may impact the risk for poor cosmetic outcome. Additionally, to quantify the rate of additional surgery needed for implant/augmentation revision due to breast cancer treatment.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Adult patients ≥ 18 years of age.
Patients treated with breast conserving surgery and radiation therapy at Mayo Clinic Florida for diagnosis of stage 0-III breast cancer.
Patients with breast implants at the time of breast cancer diagnosis.

Exclusion Criteria:

Patients without prior breast implants or treated without breast irradiation.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 12/27/22. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Jacksonville, Fla. Mayo Clinic principal investigator Sarah McLaughlin, M.D.	Closed for enrollment	Contact information: Cancer Center Clinical Trials Referral Office (855) 776-0015

Mayo Clinic Location

Status

Contact

Jacksonville, Fla.

Mayo Clinic principal investigator

Sarah McLaughlin, M.D.

Closed for enrollment

Contact information:

Cancer Center Clinical Trials Referral Office

(855) 776-0015

More information

Publications

Publications are currently not available

Clinical Trials